Hunan Hansen Pharmaceutical Co., Ltd. (002412.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.23B
Enterprise Value3.03B
P/E Ratio19.13
PEG Ratio0.71
Price/Sales Ratio4.54
Price/Book Ratio1.95
Enterprise/Revenue4.47
Enterprise/EBITDA17.22

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.23
Operating Margin0.26
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.1

Income Statement

Revenue1.04B
Revenue/Share2
Gross Profit803.62M
EBITDA281M
Net Income198.12M
Diluted EPS0.39

Balance Sheet

Total Cash442.07M
Total Cash/Share0.88
Total Debt8.42M
Total Debt/Equity0
Current Ratio14.79
Book Value Per Share4.65

Price History

52-Week Change43.29
52-Week High14.23
52-Week Low5.32
Moving Average 50 Days8.86
Moving Average 200 Days7.25

Statistics

Average Volume51.69M
Shares Outstanding503.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield3.31
Payout Ratio0.64
Last Split Factor17:10
Last Split DateMay 30, 2019
AD